Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca Bojan

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
British Journal of Haematology|April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patientsAdrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.
Journal of Hematology|November 4, 2024
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World ExperienceCiprian Jitaru, Argyris Symeonidis, Sorina Badelita, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
British Journal of Haematology|April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patientsAdrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.
Journal of Hematology|November 4, 2024
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World ExperienceCiprian Jitaru, Argyris Symeonidis, Sorina Badelita, et al.
Pageof 4